Loading clinical trials...
Loading clinical trials...
The primary purpose of this open-label study is to investigate the interaction of ketoconazole, a liver enzyme inhibitor, on oral LBH589 in adult patients with advanced solid tumors. The extension pha...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novartis Pharmaceuticals
NCT07249528 · Non-hodgkin Lymphoma, Multiple Myeloma
NCT03206060 · Pheochromocytoma, Paraganglioma, and more
NCT07542041 · Pancreatic Cancer, Pancreatic Neoplasms, and more
NCT06608446 · Breast Neoplasms
NCT07541924 · Colorectal Cancer Screening, Colonic Polyps/Colonoscopy/Colorectal Neoplasms, and more
Nevada Cancer Institute
Las Vegas, Nevada
Novartis Investigative Site
Rotterdam
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions